Insider Transactions Reported by 10 Insiders of Nuvectis Pharma, Inc.

Symbol
NVCT on Nasdaq
Location
Fort Lee, NJ

Insiders trading volume in the past year

Nuvectis Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ron Bentsur Chairman & CEO, Director, 10%+ Owner $27,752,858 +$28,600 +0.1% 06 Jan 2026
Marlio Charles Mosseri 10%+ Owner $20,355,809 +$2,890,311 +17% 23 Oct 2025
Enrique Poradosu Chief Science & Business Off $13,637,527 06 Jan 2026
Shay Shemesh Chief Dev. & Ops. Officer $13,537,484 06 Jan 2026
Michael Carson Vice President, Finance $1,510,870 06 Jan 2026
Kenneth Hoberman Director $1,122,370 12 Jun 2025
James F. Oliviero III Director $740,390 12 Jun 2025
Matthew Kaplan Director $728,598 +$64,240 +9.7% 05 Nov 2025
Juan Sanchez Director $454,986 +$75,270 +20% 05 Nov 2025
Uri Ben-Or Int. Principal Financial Off. $283,471 08 Feb 2022

Recent Insider Transactions by Companies or Individuals for Nuvectis Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.